UIPATH INC - CLASS A (PATH) Stock Fundamental Analysis

NYSE:PATH • US90364P1057

9.94 USD
-0.16 (-1.58%)
At close: Feb 25, 2026
9.9 USD
-0.04 (-0.4%)
After Hours: 2/25/2026, 7:17:47 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

PATH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 274 industry peers in the Software industry. While PATH has a great health rating, its profitability is only average at the moment. PATH is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • PATH had positive earnings in the past year.
  • In the past year PATH had a positive cash flow from operations.
  • In the past 5 years PATH always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: PATH reported negative operating cash flow in multiple years.
PATH Yearly Net Income VS EBIT VS OCF VS FCFPATH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

  • PATH has a Return On Assets of 7.93%. This is in the better half of the industry: PATH outperforms 79.93% of its industry peers.
  • PATH has a better Return On Equity (11.93%) than 75.18% of its industry peers.
  • PATH has a better Return On Invested Capital (0.88%) than 60.95% of its industry peers.
Industry RankSector Rank
ROA 7.93%
ROE 11.93%
ROIC 0.88%
ROA(3y)-5.87%
ROA(5y)-9.74%
ROE(3y)-8.52%
ROE(5y)-15%
ROIC(3y)N/A
ROIC(5y)N/A
PATH Yearly ROA, ROE, ROICPATH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200 -250

1.3 Margins

  • PATH's Profit Margin of 14.79% is fine compared to the rest of the industry. PATH outperforms 77.74% of its industry peers.
  • Looking at the Operating Margin, with a value of 1.52%, PATH is in the better half of the industry, outperforming 61.31% of the companies in the same industry.
  • The Gross Margin of PATH (83.35%) is better than 88.32% of its industry peers.
  • PATH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.52%
PM (TTM) 14.79%
GM 83.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.08%
PATH Yearly Profit, Operating, Gross MarginsPATH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PATH is destroying value.
  • PATH has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PATH has been increased compared to 5 years ago.
  • PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PATH Yearly Shares OutstandingPATH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
PATH Yearly Total Debt VS Total AssetsPATH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • PATH has an Altman-Z score of 3.56. This indicates that PATH is financially healthy and has little risk of bankruptcy at the moment.
  • PATH's Altman-Z score of 3.56 is fine compared to the rest of the industry. PATH outperforms 69.34% of its industry peers.
  • PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.56
ROIC/WACC0.08
WACC10.94%
PATH Yearly LT Debt VS Equity VS FCFPATH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • PATH has a Current Ratio of 2.65. This indicates that PATH is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.65, PATH is in the better half of the industry, outperforming 71.53% of the companies in the same industry.
  • A Quick Ratio of 2.65 indicates that PATH has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.65, PATH is in the better half of the industry, outperforming 71.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 2.65
PATH Yearly Current Assets VS Current LiabilitesPATH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • PATH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.00%, which is quite impressive.
  • Measured over the past years, PATH shows a very strong growth in Earnings Per Share. The EPS has been growing by 88.99% on average per year.
  • PATH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.05%.
  • The Revenue has been growing by 33.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)36%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%45.45%
Revenue 1Y (TTM)10.05%
Revenue growth 3Y17.01%
Revenue growth 5Y33.58%
Sales Q2Q%15.92%

3.2 Future

  • Based on estimates for the next years, PATH will show a small growth in Earnings Per Share. The EPS will grow by 1.84% on average per year.
  • Based on estimates for the next years, PATH will show a quite strong growth in Revenue. The Revenue will grow by 11.61% on average per year.
EPS Next Y26.85%
EPS Next 2Y19.81%
EPS Next 3Y15.63%
EPS Next 5Y1.84%
Revenue Next Year11.3%
Revenue Next 2Y10.39%
Revenue Next 3Y9.81%
Revenue Next 5Y11.61%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PATH Yearly Revenue VS EstimatesPATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
PATH Yearly EPS VS EstimatesPATH Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.62, the valuation of PATH can be described as correct.
  • Compared to the rest of the industry, the Price/Earnings ratio of PATH indicates a somewhat cheap valuation: PATH is cheaper than 79.56% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of PATH to the average of the S&P500 Index (27.05), we can say PATH is valued slightly cheaper.
  • PATH is valuated correctly with a Price/Forward Earnings ratio of 12.82.
  • 78.10% of the companies in the same industry are more expensive than PATH, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of PATH to the average of the S&P500 Index (28.03), we can say PATH is valued rather cheaply.
Industry RankSector Rank
PE 14.62
Fwd PE 12.82
PATH Price Earnings VS Forward Price EarningsPATH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as PATH.
  • Based on the Price/Free Cash Flow ratio, PATH is valued a bit cheaper than the industry average as 74.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.06
EV/EBITDA 86.35
PATH Per share dataPATH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • PATH's earnings are expected to grow with 15.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.54
PEG (5Y)N/A
EPS Next 2Y19.81%
EPS Next 3Y15.63%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for PATH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

UIPATH INC - CLASS A

NYSE:PATH (2/25/2026, 7:17:47 PM)

After market: 9.9 -0.04 (-0.4%)

9.94

-0.16 (-1.58%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-03
Earnings (Next)03-11
Inst Owners70.4%
Inst Owner Change1.54%
Ins Owners7.78%
Ins Owner Change2.6%
Market Cap5.32B
Revenue(TTM)1.55B
Net Income(TTM)229.66M
Analysts66.43
Price Target16.75 (68.51%)
Short Float %17.87%
Short Ratio2.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.54%
Min EPS beat(2)7.4%
Max EPS beat(2)83.69%
EPS beat(4)4
Avg EPS beat(4)31.39%
Min EPS beat(4)7.36%
Max EPS beat(4)83.69%
EPS beat(8)8
Avg EPS beat(8)29.9%
EPS beat(12)12
Avg EPS beat(12)80.56%
EPS beat(16)16
Avg EPS beat(16)90.76%
Revenue beat(2)2
Avg Revenue beat(2)2.34%
Min Revenue beat(2)2.11%
Max Revenue beat(2)2.57%
Revenue beat(4)3
Avg Revenue beat(4)1.84%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)5.03%
Revenue beat(8)6
Avg Revenue beat(8)1.45%
Revenue beat(12)9
Avg Revenue beat(12)2.16%
Revenue beat(16)13
Avg Revenue beat(16)2.46%
PT rev (1m)0%
PT rev (3m)21.38%
EPS NQ rev (1m)0.34%
EPS NQ rev (3m)-1.79%
EPS NY rev (1m)0.22%
EPS NY rev (3m)1.6%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.34%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)1.25%
Valuation
Industry RankSector Rank
PE 14.62
Fwd PE 12.82
P/S 3.42
P/FCF 17.06
P/OCF 15.87
P/B 2.76
P/tB 2.98
EV/EBITDA 86.35
EPS(TTM)0.68
EY6.84%
EPS(NY)0.78
Fwd EY7.8%
FCF(TTM)0.58
FCFY5.86%
OCF(TTM)0.63
OCFY6.3%
SpS2.9
BVpS3.6
TBVpS3.33
PEG (NY)0.54
PEG (5Y)N/A
Graham Number7.42
Profitability
Industry RankSector Rank
ROA 7.93%
ROE 11.93%
ROCE 1.12%
ROIC 0.88%
ROICexc 2.63%
ROICexgc 3.28%
OM 1.52%
PM (TTM) 14.79%
GM 83.35%
FCFM 20.06%
ROA(3y)-5.87%
ROA(5y)-9.74%
ROE(3y)-8.52%
ROE(5y)-15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.08%
F-Score8
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 153.76%
Cap/Sales 1.51%
Interest Coverage 250
Cash Conversion 863.81%
Profit Quality 135.66%
Current Ratio 2.65
Quick Ratio 2.65
Altman-Z 3.56
F-Score8
WACC10.94%
ROIC/WACC0.08
Cap/Depr(3y)82.11%
Cap/Depr(5y)72.19%
Cap/Sales(3y)1.29%
Cap/Sales(5y)1.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%45.45%
EPS Next Y26.85%
EPS Next 2Y19.81%
EPS Next 3Y15.63%
EPS Next 5Y1.84%
Revenue 1Y (TTM)10.05%
Revenue growth 3Y17.01%
Revenue growth 5Y33.58%
Sales Q2Q%15.92%
Revenue Next Year11.3%
Revenue Next 2Y10.39%
Revenue Next 3Y9.81%
Revenue Next 5Y11.61%
EBIT growth 1Y114.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.35%
EBIT Next 3Y32.44%
EBIT Next 5Y22.63%
FCF growth 1Y28.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.4%
OCF growth 3YN/A
OCF growth 5YN/A

UIPATH INC - CLASS A / PATH FAQ

What is the fundamental rating for PATH stock?

ChartMill assigns a fundamental rating of 6 / 10 to PATH.


What is the valuation status of UIPATH INC - CLASS A (PATH) stock?

ChartMill assigns a valuation rating of 6 / 10 to UIPATH INC - CLASS A (PATH). This can be considered as Fairly Valued.


What is the profitability of PATH stock?

UIPATH INC - CLASS A (PATH) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for PATH stock?

The Price/Earnings (PE) ratio for UIPATH INC - CLASS A (PATH) is 14.62 and the Price/Book (PB) ratio is 2.76.


What is the earnings growth outlook for UIPATH INC - CLASS A?

The Earnings per Share (EPS) of UIPATH INC - CLASS A (PATH) is expected to grow by 26.85% in the next year.